Uptake of combination antiretroviral therapy and HIV disease progression according to geographical origin in seroconverters in Europe, Canada, and Australia

Inma Jarrin; Nikos Pantazis; M John Gill; Ronald Geskus; Santiago Perez-Hoyos; Laurence Meyer; Maria Prins; Giota Touloumi; Anne Johnson; Osamah Hamouda; Patricia García de Olalla; Kholoud Porter; Julia del Amo; CASCADE Collaboration in EuroCoord; Ole Kirk

doi:10.1093/cid/cir814

Uptake of combination antiretroviral therapy and HIV disease progression according to geographical origin in seroconverters in Europe, Canada, and Australia

Inma Jarrin, Nikos Pantazis, M John Gill, Ronald Geskus, Santiago Perez-Hoyos, Laurence Meyer, Maria Prins, Giota Touloumi, Anne Johnson, Osamah Hamouda, Patricia García de Olalla, Kholoud Porter, Julia del Amo, CASCADE Collaboration in EuroCoord, Ole Kirk

16 Citationer (Scopus)

Abstract

We examined differences by geographical origin (GO) in time from HIV seroconversion (SC) to AIDS, death, and initiation of antiretroviral therapy (cART).

Originalsprog	Engelsk
Tidsskrift	Clinical Infectious Diseases
Vol/bind	54
Udgave nummer	1
Sider (fra-til)	111-8
Antal sider	8
ISSN	1058-4838
DOI	https://doi.org/10.1093/cid/cir814
Status	Udgivet - 2012

Adgang til dokumentet

10.1093/cid/cir814

Citationsformater

Jarrin, I., Pantazis, N., Gill, M. J., Geskus, R., Perez-Hoyos, S., Meyer, L., Prins, M., Touloumi, G., Johnson, A., Hamouda, O., de Olalla, P. G., Porter, K., del Amo, J., CASCADE Collaboration in EuroCoord, & Kirk, O. (2012). Uptake of combination antiretroviral therapy and HIV disease progression according to geographical origin in seroconverters in Europe, Canada, and Australia. Clinical Infectious Diseases, 54(1), 111-8. https://doi.org/10.1093/cid/cir814

Jarrin, I, Pantazis, N, Gill, MJ, Geskus, R, Perez-Hoyos, S, Meyer, L, Prins, M, Touloumi, G, Johnson, A, Hamouda, O, de Olalla, PG, Porter, K, del Amo, J, CASCADE Collaboration in EuroCoord & Kirk, O 2012, 'Uptake of combination antiretroviral therapy and HIV disease progression according to geographical origin in seroconverters in Europe, Canada, and Australia', Clinical Infectious Diseases, bind 54, nr. 1, s. 111-8. https://doi.org/10.1093/cid/cir814

@article{4e4c8ddfe31c495c92b69ce3ce2c7e44,

title = "Uptake of combination antiretroviral therapy and HIV disease progression according to geographical origin in seroconverters in Europe, Canada, and Australia",

abstract = "We examined differences by geographical origin (GO) in time from HIV seroconversion (SC) to AIDS, death, and initiation of antiretroviral therapy (cART).",

keywords = "Adult, Anti-HIV Agents, Antiretroviral Therapy, Highly Active, Cohort Studies, Disease Progression, Female, Geography, HIV Infections, Humans, Male, Time Factors",

author = "Inma Jarrin and Nikos Pantazis and Gill, {M John} and Ronald Geskus and Santiago Perez-Hoyos and Laurence Meyer and Maria Prins and Giota Touloumi and Anne Johnson and Osamah Hamouda and {de Olalla}, {Patricia Garc{\'i}a} and Kholoud Porter and {del Amo}, Julia and {CASCADE Collaboration in EuroCoord} and Ole Kirk",

year = "2012",

doi = "10.1093/cid/cir814",

language = "English",

volume = "54",

pages = "111--8",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "1",

}

TY - JOUR

T1 - Uptake of combination antiretroviral therapy and HIV disease progression according to geographical origin in seroconverters in Europe, Canada, and Australia

AU - Jarrin, Inma

AU - Pantazis, Nikos

AU - Gill, M John

AU - Geskus, Ronald

AU - Perez-Hoyos, Santiago

AU - Meyer, Laurence

AU - Prins, Maria

AU - Touloumi, Giota

AU - Johnson, Anne

AU - Hamouda, Osamah

AU - de Olalla, Patricia García

AU - Porter, Kholoud

AU - del Amo, Julia

AU - CASCADE Collaboration in EuroCoord

AU - Kirk, Ole

PY - 2012

Y1 - 2012

N2 - We examined differences by geographical origin (GO) in time from HIV seroconversion (SC) to AIDS, death, and initiation of antiretroviral therapy (cART).

AB - We examined differences by geographical origin (GO) in time from HIV seroconversion (SC) to AIDS, death, and initiation of antiretroviral therapy (cART).

KW - Adult

KW - Anti-HIV Agents

KW - Antiretroviral Therapy, Highly Active

KW - Cohort Studies

KW - Disease Progression

KW - Female

KW - Geography

KW - HIV Infections

KW - Humans

KW - Male

KW - Time Factors

U2 - 10.1093/cid/cir814

DO - 10.1093/cid/cir814

M3 - Journal article

C2 - 22109944

SN - 1058-4838

VL - 54

SP - 111

EP - 118

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 1

ER -

Uptake of combination antiretroviral therapy and HIV disease progression according to geographical origin in seroconverters in Europe, Canada, and Australia

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater